Search Results - "Scalisi, I"
-
1
-
2
-
3
-
4
-
5
Risk of hepatocellular carcinoma recurrence in hepatitis C cirrhotic patients treated with direct acting antivirals
Published in Journal of hepatology (2017)Get full text
Journal Article -
6
Non-invasive tools to ruling out large varices: RESIST-HCV vs Baveno VI criteria in a large cohort of patients with HCV cirrhosis
Published in Digestive and liver disease (16-02-2017)Get full text
Journal Article -
7
-
8
Early occurrence of hepatocellular carcinoma (HCC) in patients with HCV cirrhosis treated with direct-acting antivirals (DAAs)
Published in Digestive and liver disease (16-02-2017)Get full text
Journal Article -
9
Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
Published in Digestive and liver disease (16-02-2017)Get full text
Journal Article -
10
Treatment of elderly HCV patients with severe fibrosis: safety and efficacy data from RESIST-HCV, a large regional database
Published in Digestive and liver disease (10-02-2016)Get full text
Journal Article -
11
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct‐acting antivirals? A prospective multicentre study
Published in Alimentary pharmacology & therapeutics (01-10-2017)“…Summary Background Data on HCV‐related hepatocellular carcinoma (HCC) early recurrence in patients whose HCC was previously cured, and subsequently treated by…”
Get full text
Journal Article -
12
RESIST-NASH: a regional network for identification and referral of masld patients at risk for liver fibrosis
Published in Digestive and liver disease (01-02-2024)Get full text
Journal Article -
13
Efficacy and safety of pangenotypic DAAs for chronic HCV infection: real-world data from the RESIST-HCV cohort
Published in Digestive and liver disease (01-03-2022)Get full text
Journal Article -
14
-
15
Second-generation DAAs for HCV: real-life efficacy in the RESIST-HCV cohort
Published in Digestive and liver disease (01-10-2019)Get full text
Journal Article -
16
Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Published in Digestive and liver disease (01-02-2019)Get full text
Journal Article -
17
PS-149 - Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort
Published in Journal of hepatology (01-04-2018)Get full text
Journal Article -
18
Disease outcomes after DAA-induced SVR: data from the resist-HCV cohort
Published in Journal of hepatology (01-04-2018)Get full text
Journal Article -
19
-
20